Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

KM-408, a novel phenoxyalkyl derivative as a potential anticonvulsant and analgesic compound for the treatment of neuropathic pain

Pharmacological Reports(2022)10.1007/s43440-022-00431-7Source: DataRank Database

KM-408, a novel phenoxyalkyl derivative as a potential anticonvulsant and analgesic compound for the treatment of neuropathic pain is a research paper published in Pharmacological Reports (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.11)OA: hybridTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Henryk Marona ORCID,Katarzyna Pańczyk ORCID,Barbara Filipek ORCID,Anna Rapacz ORCID,Kinga Sałat ORCID

Live enrichment

PubMed:36401763 PMC:PMC9889419 OpenAlex:https://openalex.org/W4309409246

European Regional Development Fund through the Innovative Economy Program

Grant: 01.01.02-12-012/09

Uniwersytet Jagielloński Collegium Medicum

Grant: N42/DBS/000234

FWCI

0.11

Citation Percentile

0.4%

Citation Trend

2025

hybridLicense: cc-by

journalhttps://doi.org/10.1007/s43440-022-00431-7

publisherhttps://doi.org/10.1007/s43440-022-00431-7

publisherhttps://link.springer.com/content/pdf/10.1007/s43440-022-00431-7.pdf

publisherhttps://link.springer.com/article/10.1007/s43440-022-00431-7/fulltext.html

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36401763

Fields of Study

Pain Mechanisms and TreatmentsNeuroscience and Neuropharmacology ResearchPharmacological Receptor Mechanisms and EffectsRatsMiceAnimalsGuinea PigsAnticonvulsantsNeuralgiaAnalgesicsEpilepsyCapsaicinDisease Models, Animal

MeSH Terms

AnalgesicsAnimalsAnticonvulsantsCapsaicinDisease Models, AnimalEpilepsyGuinea PigsNeuralgiaMiceRats

Keywords

Neuropathic painAnticonvulsantAnalgesicMedicinePharmacologyDerivative (finance)AnesthesiaPharmacotherapyEpilepsyPsychiatryMetabolitesSynthesisPharmacokinetics5-HTSafety ProfileAminoalkanolsDegradation StudiesSigma (Σ)

Sustainable Development Goals

SDG 0: Good health and well-being

KM-408, a novel phenoxyalkyl derivative as a potential anticonvulsant and analgesic compound for the treatment of neuropathic pain

FAIR Checklist

Authors (19)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)